ADAMTS9 and neoplasm: Obviously, the average tumour sizes were significantly smaller after overexpression of ADAMTS9‐AS1 and the growth rates of tumours also indicated that ADAMTS9‐AS1 could inhibit tumour growth in vivo (Figure 3F‐H).